MedicaidCoverageMedium impact
Silver State Scripts Board (SSSB) Made Changes to the Preferred Drug List (PDL) Effective October 10, 2024
Nevada Medicaid·NV · Cardiology, Endocrinology, Neurology +5 more·Pharmacy
Effective date
Oct 10, 2024
We identified it
Jun 21, 2026
Summary
Nevada Medicaid updated their Preferred Drug List (PDL) effective October 10, 2024, with multiple drug coverage changes across various therapeutic categories. Several medications moved from preferred to non-preferred status, new generic drugs were added as preferred, and some drugs were removed due to discontinuation.
Action Required
Immediately: Billing and pharmacy teams must review current Nevada Medicaid patients' medications against the updated PDL. Update prior authorization processes for drugs that moved to non-preferred status (Corlanor, Taltz, Mirapex ER, Vigamox, and others). Verify coverage for new non-preferred additions before dispensing. Review formulary preferences in practice management systems to reflect current preferred alternatives.